Schizophrenia

Showing NaN - NaN of 113

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Bipolar Disorder, Schizophrenia, Agitation,Psychomotor Trial in Little Rock, Rogers (Sublingual film containing Igalmi)

Recruiting
  • Bipolar Disorder
  • +4 more
  • Sublingual film containing Igalmi
  • Little Rock, Arkansas
  • +1 more
Sep 21, 2023

Agitation,Psychomotor, Bipolar I Disorder, Bipolar II Disorder Trial in United States (BXCL501, Matching Placebo)

Recruiting
  • Agitation,Psychomotor
  • +5 more
  • Little Rock, Arkansas
  • +16 more
Jan 31, 2023

Schizophrenia Trial in San Diego, Richardson (CVL-231 10 mg, Required CVL-231 30 mg, Placebo)

Recruiting
  • Schizophrenia
  • CVL-231 10 mg
  • +2 more
  • Little Rock, Arkansas
  • +15 more
Jan 27, 2023

Schizophrenia Trial in Worldwide (BI 425809, Placebo)

Recruiting
  • Schizophrenia
  • Little Rock, Arkansas
  • +80 more
Jan 23, 2023

Schizophrenia Trial in United States (Xanomeline and Trospium Chloride Capsules)

Recruiting
  • Schizophrenia
  • Xanomeline and Trospium Chloride Capsules
  • Little Rock, Arkansas
  • +52 more
Jan 17, 2023

Schizophrenia Trial in Worldwide (MK-8189, Risperidone, Placebo to MK-8189)

Recruiting
  • Schizophrenia
  • Bentonville, Arkansas
  • +92 more
Jan 5, 2023

Schizophrenia Trial (NBI-1117568, Placebo)

Recruiting
  • Schizophrenia
  • Little Rock, Arkansas
  • +7 more
Dec 22, 2022

Schizophrenia Trial in Worldwide (SEP-363856 50mg, SEP-363856 75mg, Placebo)

Recruiting
  • Schizophrenia
  • SEP-363856 50mg
  • +2 more
  • Little Rock, Arkansas
  • +58 more
Dec 12, 2022

Schizophrenia Trial in Worldwide (SEP-363856 75mg, SEP-363856 100mg, Placebo)

Recruiting
  • Schizophrenia
  • SEP-363856 75mg
  • +2 more
  • Little Rock, Arkansas
  • +63 more
Dec 12, 2022

Schizophrenia Trial (CVL-231 30 mg)

Enrolling by invitation
  • Schizophrenia
  • CVL-231 30 mg
  • Bentonville, Arkansas
  • +16 more
Dec 7, 2022

Schizophrenia Trial in United States (SEP-363856, Prior antipsychotic (risperidone, olanzapine, quetiapine or aripiprazole))

Recruiting
  • Schizophrenia
  • SEP-363856
  • Prior antipsychotic (risperidone, olanzapine, quetiapine or aripiprazole)
  • Little Rock, Arkansas
  • +6 more
Nov 11, 2022

Schizophrenia Trial in Worldwide (BI 425809, Placebo)

Completed
  • Schizophrenia
  • BI 425809
  • Placebo
  • Little Rock, Arkansas
  • +50 more
Nov 7, 2022

Schizophrenia Trial in Worldwide (Placebo, AVP-786)

Recruiting
  • Schizophrenia
  • Little Rock, Arkansas
  • +81 more
Aug 23, 2022

Schizophrenia Trial in United States (Xanomeline and Trospium Chloride Capsules, Placebo)

Recruiting
  • Schizophrenia
  • Xanomeline and Trospium Chloride Capsules
  • Placebo
  • Little Rock, Arkansas
  • +18 more
Aug 12, 2022

Schizophrenia, Schizophrenia; Psychosis Trial in Ukraine, United States (Xanomeline and Trospium Chloride Capsules, Placebo)

Recruiting
  • Schizophrenia
  • Schizophrenia; Psychosis
  • Xanomeline and Trospium Chloride Capsules
  • Placebo
  • Bentonville, Arkansas
  • +28 more
Aug 12, 2022

Blood Pressure, Schizophrenia Trial in United States (CVL-231)

Active, not recruiting
  • Blood Pressure
  • Schizophrenia
  • Bentonville, Arkansas
  • +9 more
Jul 11, 2022

Schizophrenia, Psychotic Disorders, Mood Disorders Trial in United States (LY03010 156 mg treatment group, deltoid, LY03010 156

Recruiting
  • Schizophrenia
  • +11 more
  • LY03010 156 mg treatment group, deltoid
  • +3 more
  • Little Rock, Arkansas
  • +8 more
Apr 11, 2022

Schizophrenia Trial in United States (Brilaroxazine, Placebo)

Recruiting
  • Schizophrenia
  • Phoenix, Arizona
  • +17 more
Apr 1, 2022

Schizophrenia, Schizophreniform Disorder, Bipolar I Disorder Trial in Worldwide (ALKS 3831)

Active, not recruiting
  • Schizophrenia
  • +2 more
  • ALKS 3831
  • Little Rock, Arkansas
  • +85 more
Feb 10, 2022

Schizophrenia Trial in Worldwide (SEP-363856)

Completed
  • Schizophrenia
  • Little Rock, Arkansas
  • +29 more
Feb 8, 2022

Schizophrenia, Schizophreniform Disorders, Bipolar I Disorder Trial in Worldwide (ALKS 3831, Olanzapine)

Completed
  • Schizophrenia
  • +2 more
  • Little Rock, Arkansas
  • +56 more
Jan 5, 2022

Schizophrenia Trial in United States (CTP-692, Placebo)

Completed
  • Schizophrenia
  • Little Rock, Arkansas
  • +23 more
Dec 13, 2021

Schizophrenia Trial in Worldwide (Pimavanserin)

Recruiting
  • Schizophrenia
  • Phoenix, Arizona
  • +147 more
Oct 12, 2021

Schizophrenia, Alcohol Use Disorder Trial in Bulgaria, Poland, United States (Samidorphan + olanzapine (ALKS 3831), Placebo +

Completed
  • Schizophrenia
  • Alcohol Use Disorder
  • Samidorphan + olanzapine (ALKS 3831)
  • Placebo + olanzapine
  • Little Rock, Arkansas
  • +70 more
Sep 14, 2021

Schizophrenia Trial in Bulgaria, Czechia, United States (Samidorphan (Low Dose), Samidorphan (Medium Dose), Samidorphan (High

Completed
  • Schizophrenia
  • Samidorphan (Low Dose)
  • +4 more
  • Little Rock, Arkansas
  • +60 more
Sep 10, 2021